78 research outputs found
Neural Network-Based Joint Spatial and Temporal Equalization for MIMO-VLC System
The limited bandwidth of white light-emitting diode (LED) limits the achievable data rate in a visible light communication (VLC) system. A number of techniques, including multiple-input-multiple-output (MIMO) system, are investigated to increase the data rate. The high-speed optical MIMO system suffers from both spatial and temporal cross talks. The spatial cross-talk is often compensated by the MIMO decoding algorithm, while the temporal cross talk is mitigated using an equalizer. However, the LEDs have a non-linear transfer function and the performance of linear equalizers are limited. In this letter, we propose a joint spatial and temporal equalization using an artificial neural network (ANN) for an MIMO-VLC system. We demonstrate using a practical imaging/non-imaging optical MIMO link that the ANN-based joint equalization outperforms the joint equalization using a traditional decision feedback as ANN is able to compensate the non-linear transfer function as well as cross talk
A Multi-Gigabit/sec Integrated Multiple Input Multiple Output VLC Demonstrator
In this paper, we report the performance of an imaging multiple input multiple output (MIMO) visible light communication (VLC) system. The VLC transmitter consists of a two-dimensional, individually addressable Gallium Nitride micro light emitting diode (µLED) array. The receiver uses a two-dimensional avalanche photodiode (APD) array fabricated using complementary metal oxide semiconductor (CMOS). Using integrated CMOS-based LED drivers, a data rate greater than 1 Gbps was obtained at a link distance of 1 m with the system field of view (FOV) of 3.45 degree using four channels. At a reduced link distance of 0.5 m, a data rate of 7.48 Gbps was obtained using a nine channel MIMO system. This demonstrates the feasibility of compact MIMO systems which offer substantial data rates
Flexible Glass Hybridized Colloidal Quantum Dots for Gb/s Visible Light Communications
Color converting films of colloidal quantum dots (CQDs) encapsulated with flexible glass are integrated with microsize GaN LEDs (μLEDs) in order to form optical sources for high-speed visible light communications (VLC). VLC is an emerging technology that uses white and/or colored light from LEDs to combine illumination and display functions with the transmission of data. The flexible glass/CQD format addresses the issue of limited modulation speed of typical phosphor-converted LEDs while enhancing the photostability of the color converters and facilitating their integration with the μLEDs. These structures are less than 70 μm in total thickness and are directly placed in contact with the polished sapphire substrate of 450-nm-emitting μLEDs. Blue-to-green, blue-to-orange and blue-to-red conversion with respective forward optical power conversion efficiencies of 13%, 12% and 5.5% are reported. In turn, free-space optical communications up to 1.4 Gb/s VLC is demonstrated. Results show that CQD-converted LEDs pave the way for practical digital lighting/displays with multi-Gb/s capability
Influenza Outbreaks during World Youth Day 2008 Mass Gathering
Novel viruses were introduced and seasonal viruses were amplified
Visual hallucinations in the psychosis spectrum and comparative information from neurodegenerative disorders and eye disease
Much of the research on visual hallucinations (VHs) has been conducted in the context of eye disease and neurodegenerative conditions, but little is known about these phenomena in psychiatric and nonclinical populations. The purpose of this article is to bring together current knowledge regarding VHs in the psychosis phenotype and contrast this data with the literature drawn from neurodegenerative disorders and eye disease. The evidence challenges the traditional views that VHs are atypical or uncommon in psychosis. The weighted mean for VHs is 27% in schizophrenia, 15% in affective psychosis, and 7.3% in the general community. VHs are linked to a more severe psychopathological profile and less favorable outcome in psychosis and neurodegenerative conditions. VHs typically co-occur with auditory hallucinations, suggesting a common etiological cause. VHs in psychosis are also remarkably complex, negative in content, and are interpreted to have personal relevance. The cognitive mechanisms of VHs in psychosis have rarely been investigated, but existing studies point to source-monitoring deficits and distortions in top-down mechanisms, although evidence for visual processing deficits, which feature strongly in the organic literature, is lacking. Brain imaging studies point to the activation of visual cortex during hallucinations on a background of structural and connectivity changes within wider brain networks. The relationship between VHs in psychosis, eye disease, and neurodegeneration remains unclear, although the pattern of similarities and differences described in this review suggests that comparative studies may have potentially important clinical and theoretical implications. © 2014 The Author
Combined point of care nucleic acid and antibody testing for SARS-CoV-2 following emergence of D614G Spike Variant
Rapid COVID-19 diagnosis in hospital is essential, though complicated by 30-50% of nose/throat swabs being negative by SARS-CoV-2 nucleic acid amplification testing (NAAT). Furthermore, the D614G spike mutant now dominates the pandemic and it is unclear how serological tests designed to detect anti-Spike antibodies perform against this variant. We assess the diagnostic accuracy of combined rapid antibody point of care (POC) and nucleic acid assays for suspected COVID-19 disease due to either wild type or the D614G spike mutant SARS-CoV-2. The overall detection rate for COVID-19 is 79.2% (95CI 57.8-92.9%) by rapid NAAT alone. Combined point of care antibody test and rapid NAAT is not impacted by D614G and results in very high sensitivity for COVID-19 diagnosis with very high specificity
Ten-year mortality, disease progression, and treatment-related side effects in men with localised prostate cancer from the ProtecT randomised controlled trial according to treatment received
Background
The ProtecT trial reported intention-to-treat analysis of men with localised prostate cancer randomly allocated to active monitoring (AM), radical prostatectomy, and external beam radiotherapy.
Objective
To report outcomes according to treatment received in men in randomised and treatment choice cohorts.
Design, setting, and participants
This study focuses on secondary care. Men with clinically localised prostate cancer at one of nine UK centres were invited to participate in the treatment trial comparing AM, radical prostatectomy, and radiotherapy.
Intervention
Two cohorts included 1643 men who agreed to be randomised and 997 who declined randomisation and chose treatment.
Outcome measurements and statistical analysis
Analysis was carried out to assess mortality, metastasis and progression and health-related quality of life impacts on urinary, bowel, and sexual function using patient-reported outcome measures. Analysis was based on comparisons between groups defined by treatment received for both randomised and treatment choice cohorts in turn, with pooled estimates of intervention effect obtained using meta-analysis. Differences were estimated with adjustment for known prognostic factors using propensity scores.
Results and limitations
According to treatment received, more men receiving AM died of PCa (AM 1.85%, surgery 0.67%, radiotherapy 0.73%), whilst this difference remained consistent with chance in the randomised cohort (p = 0.08); stronger evidence was found in the exploratory analyses (randomised plus choice cohort) when AM was compared with the combined radical treatment group (p = 0.003). There was also strong evidence that metastasis (AM 5.6%, surgery 2.4%, radiotherapy 2.7%) and disease progression (AM 20.35%, surgery 5.87%, radiotherapy 6.62%) were more common in the AM group. Compared with AM, there were higher risks of sexual dysfunction (95% at 6 mo) and urinary incontinence (55% at 6 mo) after surgery, and of sexual dysfunction (88% at 6 mo) and bowel dysfunction (5% at 6 mo) after radiotherapy. The key limitations are the potential for bias when comparing groups defined by treatment received and changes in the protocol for AM during the lengthy follow-up required in trials of screen-detected PCa.
Conclusions
Analyses according to treatment received showed increased rates of disease-related events and lower rates of patient-reported harms in men managed by AM compared with men managed by radical treatment, and stronger evidence of greater PCa mortality in the AM group.
Patient summary
More than 95 out of every 100 men with low or intermediate risk localised prostate cancer do not die of prostate cancer within 10 yr, irrespective of whether treatment is by means of monitoring, surgery, or radiotherapy. Side effects on sexual and bladder function are better after active monitoring, but the risks of spreading of prostate cancer are more common
Genetic correlation between amyotrophic lateral sclerosis and schizophrenia
A. Palotie on työryhmän Schizophrenia Working Grp Psychiat jäsen.We have previously shown higher-than-expected rates of schizophrenia in relatives of patients with amyotrophic lateral sclerosis (ALS), suggesting an aetiological relationship between the diseases. Here, we investigate the genetic relationship between ALS and schizophrenia using genome-wide association study data from over 100,000 unique individuals. Using linkage disequilibrium score regression, we estimate the genetic correlation between ALS and schizophrenia to be 14.3% (7.05-21.6; P = 1 x 10(-4)) with schizophrenia polygenic risk scores explaining up to 0.12% of the variance in ALS (P = 8.4 x 10(-7)). A modest increase in comorbidity of ALS and schizophrenia is expected given these findings (odds ratio 1.08-1.26) but this would require very large studies to observe epidemiologically. We identify five potential novel ALS-associated loci using conditional false discovery rate analysis. It is likely that shared neurobiological mechanisms between these two disorders will engender novel hypotheses in future preclinical and clinical studies.Peer reviewe
Robust estimation of bacterial cell count from optical density
Optical density (OD) is widely used to estimate the density of cells in liquid culture, but cannot be compared between instruments without a standardized calibration protocol and is challenging to relate to actual cell count. We address this with an interlaboratory study comparing three simple, low-cost, and highly accessible OD calibration protocols across 244 laboratories, applied to eight strains of constitutive GFP-expressing E. coli. Based on our results, we recommend calibrating OD to estimated cell count using serial dilution of silica microspheres, which produces highly precise calibration (95.5% of residuals <1.2-fold), is easily assessed for quality control, also assesses instrument effective linear range, and can be combined with fluorescence calibration to obtain units of Molecules of Equivalent Fluorescein (MEFL) per cell, allowing direct comparison and data fusion with flow cytometry measurements: in our study, fluorescence per cell measurements showed only a 1.07-fold mean difference between plate reader and flow cytometry data
- …